GMMPFAUDLRBSEGMM PFAUDLER LIMITEDHighNeutral
Announced Tue, 15 Sept, 2026 · 17:06 IST

GMM Pfaudler CFO change: Poempner resigns, Ankit Nayyar takes over

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

GMMPFAUDLR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.8%Reaction day
₹1350.00
prior close
₹1348.00
announcement price
After-mkt
timing
Nifty Microcap 250market-0.1%-0.7% vs market
Industrial Products peers, median of 134sector-0.5%-0.3% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.3 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.7
10m
-1.5
15m
-1.2
30m
-2.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.8-0.1-0.7-0.5-0.3
Next day
+1.2+0.7+0.5+0.3+1.0
2d
+8.1+2.3+5.8+1.0+7.2
3d
+11.5+2.2+9.3+1.1+10.4
4d
+8.1+2.6+5.5+1.5+6.6
5d
+5.8+3.9+1.8+2.1+3.6
1w
+11.1+2.7+8.4+1.5+9.6
15d
-0.5-1.2+0.7-1.8+1.3
1m
-3.0-0.2-2.8-0.5-2.5
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 134Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of GMM Pfaudler approved the resignation of Group CFO Mr. Alexander Poempner, effective from the close of the Q2 FY27 results board meeting on November 4, 2026. He will stay on until December 31, 2026 to ensure smooth handover after about 5 years in the role. Mr. Ankit Nayyar, currently Deputy CFO (joined May 2026), will take over as the new Group CFO from November 4, 2026. Nayyar is a Chartered Accountant with nearly two decades of experience spanning pharma, specialty chemicals and financial services, previously CFO of PI Health Sciences, and held senior roles at Pfizer, Bayer Monsanto India, MSCI and Tata AIG.

Likely market impact

Orderly CFO transition with internal-elevated successor. Nayyar brings strong pharma and chemicals finance experience. Short-term disruption expected to be minimal.